Private company
Telesis Bio Inc.
American laboratory analytical instruments company based in San Diego.
Last updated Oct 18, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
61.6%Gross margin3
-169.2%Operating margin3
-173.5%Net margin3
0.3%Revenue growth, 20233
-20052.1%Return on equity3
22.14×Debt to equity3
-$36.6MFree cash flow3
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Cost of revenue34¢$10.6M
- Research and development56¢$17.5M
- Interest10¢$3.1M
- Income tax0¢$24.0K
Out of $27.5M in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | $6.6M4 | $11.0M5 | $27.4M3 | $27.5M3 | |
| Cost of revenue | $3.0M4 | $6.7M5 | $11.8M3 | $10.6M3 | |
| Gross profit | $3.6M4 | $4.3M5 | $15.6M3 | $16.9M3 | |
| Research and development | $8.9M4 | $14.5M5 | $23.5M3 | $17.5M3 | |
| Operating income | -$16.4M4 | -$35.4M5 | -$46.5M3 | -$46.5M3 | |
| Interest | $2.0M3 | $3.1M3 | |||
| Income tax | $5.0K4 | $14.0K5 | $24.0K3 | $24.0K3 | |
| Net income | -$18.0M4 | -$39.0M5 | -$48.5M3 | -$47.7M3 | |
| Earnings per share | -$3.604 | -$2.145 | -$1.653 | -$1.643 | |
| Earnings per share (diluted) | -$3.604 | -$2.145 | -$1.653 | -$1.643 |
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Cash | $29.1M4 | $13.5M4 | $82.8M5 | $30.4M3 | $1.6M3 |
| Current assets | $17.2M4 | $93.2M5 | $55.1M3 | $30.4M3 | |
| Total assets | $26.9M4 | $116.3M5 | $81.4M3 | $70.4M3 | |
| Current liabilities | $5.6M4 | $9.7M5 | $13.5M3 | $8.2M3 | |
| Long-term debt | $3.4M4 | $14.1M5 | $19.6M3 | $5.3M3 | |
| Total liabilities | $13.4M4 | $25.5M5 | $34.8M3 | $40.9M3 | |
| Shareholders’ equity | -$7.5M4 | -$25.5M5 | $90.8M3 | $46.6M3 | $238.0K3 |
| Shares outstanding | 5.0M shares4 | 29.3M shares5 | 29.6M shares3 | 30.1M shares3 |
Leadership
Who has led Telesis Bio Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
2025
- Chief executive officerEric Eugene Esser Apr 19, 2024 to Apr 19, 20248
- Chief executive officerTodd Robert Nelson Jun 17, 2021 to Mar 5, 20249
- PresidentEric Eugene Esser Mar 5, 2024 to Apr 19, 202410
- PresidentTodd Robert Nelson Jun 17, 2021 to Feb 29, 20249
- Chief financial officerWilliam J. Kullback Dec 5, 2023 to Dec 5, 202311
- Chief financial officerJennifer Isacoff McNealey Jun 17, 2021 to Mar 1, 202212
- Chief operating officerEric Eugene Esser Jun 17, 2022 to Mar 5, 202413
Board members and other officers (17)
- Sr. Director Corp ControllerBrent M. Hunter Jun 17, 2021 to Aug 8, 202214
- Chief Technology OfficerDaniel Glenn Gibson Jun 17, 2021 to Mar 5, 202415
- SVP Commercial OperationsTimothy E. Cloutier Jun 17, 2021 to Jun 17, 202116
- Board memberEric Eugene Esser Apr 19, 2024 to Apr 19, 20248
- Board memberJames B. Weissman Jul 25, 2024 to Jul 26, 202417
- Board memberMichael R. Hodges Jul 25, 2024 to Jul 26, 202418
- Board memberSarah H. McConnell Jul 25, 2024 to Jul 26, 202419
- Board memberTodd Krueger Jul 25, 2024 to Jul 26, 202420
- Board memberMichael P. Rubin Jun 7, 2023 to Jun 7, 202321
- Board memberPaul M. Meister Jun 8, 2023 to Jun 8, 202322
- Board memberGregory J. Herrema Oct 25, 2023 to May 3, 202423
- Board memberAnnette Tumolo Jul 22, 2022 to May 3, 202424
- Board memberChristine A. Tsingos Jun 17, 2021 to May 3, 202425
- Board memberFrank Witney Jun 17, 2021 to May 3, 202426
- Board memberJami K. Nachtsheim Jun 17, 2021 to May 3, 202427
- Board memberTodd Robert Nelson Jun 17, 2021 to Mar 5, 20249
- General counselRob Cutler May 5, 2023 to Mar 5, 202428
Former names
- Codex DNA, Inc.Mar 16, 2021 to Oct 28, 20222
Timeline
Filings
159 filings to the SEC since October 2021: 6 annual reports, 10 quarterly reports, 43 major events, 56 insider forms, 15 large holders, 1 private raises, 28 other. The latest 20:
- Jan 14, 202515-12G EDGAR
- Jan 6, 2025EFFECT EDGAR
- Jan 6, 2025EFFECT EDGAR
- Jan 3, 2025POS AM EDGAR
- Jan 3, 2025POS AM EDGAR
- Jan 3, 2025S-8 POS EDGAR
- Jan 3, 2025S-8 POS EDGAR
- Jan 3, 2025S-8 POS EDGAR
- Jan 3, 2025S-8 POS EDGAR
- Nov 8, 20248-K EDGAR
- Nov 7, 202410-Q EDGAR
- Nov 6, 2024SC 13D/A EDGAR
- Nov 6, 2024SC 13D/A EDGAR
- Oct 25, 20248-K EDGAR
- Sep 20, 202425 EDGAR
- Sep 10, 20248-K EDGAR
- Aug 30, 20248-K EDGAR
- Aug 28, 20248-K EDGAR
- Aug 20, 20248-K EDGAR
- Aug 8, 202410-Q EDGAR
The 159 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 15 such filings since October 2021, the latest 10:
- Nov 6, 2024SC 13D/A
- Nov 6, 2024SC 13D/A
- Jul 18, 2024SC 13D/A
- Jul 18, 2024SC 13D/A
- Jun 10, 2024SC 13D/A
- Jun 10, 2024SC 13D/A
- Jul 5, 2023SC 13G/A
- Jul 5, 2023SC 13G/A
- Jun 15, 2023SC 13D
- Jun 7, 2023SC 13D/A
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Money raised
Private offerings the company reported to the SEC on Form D.
- Jun 5, 2023Raised $28 million in a private offering of equity Form D: $74.2 million offered in all Form D
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGAREric Eugene Esser, President
- 11
- 12
- 13
- 14
- 15
- 16
- 17SEC EDGARJames B. Weissman, Board member
- 18SEC EDGARMichael R. Hodges, Board member
- 19SEC EDGARSarah H. McConnell, Board member
- 20SEC EDGARTodd Krueger, Board member
- 21SEC EDGARMichael P. Rubin, Board member
- 22SEC EDGARPaul M. Meister, Board member
- 23SEC EDGARGregory J. Herrema, Board member
- 24SEC EDGARAnnette Tumolo, Board member
- 25SEC EDGARChristine A. Tsingos, Board member
- 26SEC EDGARFrank Witney, Board member
- 27SEC EDGARJami K. Nachtsheim, Board member
- 28SEC EDGARRob Cutler, General counsel
- 29